Clinical Trials Directory

Trials / Completed

CompletedNCT03627780

Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)

Genetic Polymorphism Associated With the Occurrence of Postoperative Vomiting and Vomiting (PONV) in Patients Undergoing Oncological Surgeries

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Instituto do Cancer do Estado de São Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nausea and vomiting affects 25-30% of individuals in the post-operative period and can reach more than 70-80% in high-risk patients. inherited factors may play a significant role in individual susceptibility and clinical research on hereditary factors involved in the pathogenesis of Postoperative nausea and vomiting (PONV) and chemotherapy nausea and vomiting (CINV) is relatively new. The aim of this study is to investigate whether inter-individual differences related to PONV are associated with genetic factors. 300 patients will be evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out Procedure method and processed to genotyping for 48 SNPs from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with demographic data and factors related to surgery will be analyzed by univariate and multivariate analysis.

Detailed description

The aim of this study is to investigate whether inter-individual differences related to PONV are associated with genetic factors. 300 patients will be evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out Procedure method and processed to genotyping for 48 single nucleotide polymorphisms (SNPs) from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with demographic data and factors related to surgery will be analyzed by univariate and multivariate analysis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDNA extractionDNA will be extracted from white cells

Timeline

Start date
2017-01-02
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2018-08-13
Last updated
2021-05-19

Locations

2 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03627780. Inclusion in this directory is not an endorsement.